2020
Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection
Hummel JP, Maraj I, Taoutel R, Chamoun R, Workman VK, Tran L, Abboud JM, Afif C, Chouairi S, Delvecchio A, Howes CJ, Enriquez AD, Akar JG. Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection. Circulation Arrhythmia And Electrophysiology 2020, 13: e008841-e008841. PMID: 32931318, PMCID: PMC7566294, DOI: 10.1161/circep.120.008841.Peer-Reviewed Original Research
2018
A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today?
Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal Of Cardiovascular Pharmacology And Therapeutics 2018, 24: 3-10. PMID: 29940780, DOI: 10.1177/1074248418784288.Peer-Reviewed Original ResearchConceptsAtrial fibrillationAtrial flutterClass III antiarrhythmic agentPost-myocardial infarction patientsAcceptable renal functionAtrioventricular nodal blockadeAcceptable safety profileNormal QT intervalParoxysmal atrial fibrillationReal-world efficacyCreatinine clearanceRenal functionSymptomatic patientsHeart failureAtrial tachycardiaPersistent arrhythmiaSafety profileSinus rhythmAntiarrhythmic agentsInfarction patientsVentricular tachycardiaClinical trialsQT intervalDrug trialsDrug Administration